1. Home
  2. GDTC vs FCUV Comparison

GDTC vs FCUV Comparison

Compare GDTC & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • FCUV
  • Stock Information
  • Founded
  • GDTC 2018
  • FCUV 2012
  • Country
  • GDTC Singapore
  • FCUV United States
  • Employees
  • GDTC N/A
  • FCUV N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • FCUV Industrial Machinery/Components
  • Sector
  • GDTC Health Care
  • FCUV Industrials
  • Exchange
  • GDTC Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • GDTC 28.0M
  • FCUV 27.6M
  • IPO Year
  • GDTC 2023
  • FCUV N/A
  • Fundamental
  • Price
  • GDTC $2.31
  • FCUV $3.90
  • Analyst Decision
  • GDTC Buy
  • FCUV
  • Analyst Count
  • GDTC 1
  • FCUV 0
  • Target Price
  • GDTC $5.00
  • FCUV N/A
  • AVG Volume (30 Days)
  • GDTC 5.7K
  • FCUV 14.5K
  • Earning Date
  • GDTC 01-01-0001
  • FCUV 08-13-2025
  • Dividend Yield
  • GDTC N/A
  • FCUV N/A
  • EPS Growth
  • GDTC N/A
  • FCUV N/A
  • EPS
  • GDTC N/A
  • FCUV N/A
  • Revenue
  • GDTC $368,838.00
  • FCUV $408,887.00
  • Revenue This Year
  • GDTC $5.37
  • FCUV N/A
  • Revenue Next Year
  • GDTC N/A
  • FCUV N/A
  • P/E Ratio
  • GDTC N/A
  • FCUV N/A
  • Revenue Growth
  • GDTC N/A
  • FCUV 6.49
  • 52 Week Low
  • GDTC $1.20
  • FCUV $1.50
  • 52 Week High
  • GDTC $4.05
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 55.02
  • FCUV 45.52
  • Support Level
  • GDTC $2.08
  • FCUV $3.75
  • Resistance Level
  • GDTC $2.34
  • FCUV $4.23
  • Average True Range (ATR)
  • GDTC 0.10
  • FCUV 0.23
  • MACD
  • GDTC 0.00
  • FCUV 0.03
  • Stochastic Oscillator
  • GDTC 85.71
  • FCUV 45.45

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: